Triptolide inhibits CC chemokines expressed in rat adjuvant-induced arthritis

International Immunopharmacology

Volumn 6, Issue 12, 2006, Pages 1825-1832

  Wang, Yifan ^a   Wei, Dengming ^b   Lai, Zheng ^a   Le, Yanping ^b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

Adjuvant induced arthritis; Chemokines; Triptolide

Indexed keywords

BETA CHEMOKINE; FREUND ADJUVANT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRIPTOLIDE;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; SYNOVIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINE CCL5; DITERPENES; EPOXY COMPOUNDS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSIVE AGENTS; KNEE JOINT; LEUKOCYTES, MONONUCLEAR; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGE INFLAMMATORY PROTEINS; PHENANTHRENES; RANTES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33750044886     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.07.029     Document Type: Article

References (33)

1. Godessart N., and Kunkel S.L. Chemokines in autoimmune disease. Curr Opin Immunol 13 (2001) 670-675
2. Koch A.E. Chemokines and their receptors in rheumatoid arthritis: future targets?. Arthritis Rheum 52 (2005) 710-721
3. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
4. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 20 (1999) 254-257
5. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K., et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90 (1992) 772-779
6. Koch A.E., Kunkel S.L., Harlow L.A., Mazarakis D.D., Haines G.K., Burdick M.D., et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 93 (1994) 921-928
7. Volin M.V., Shah M.R., Tokuhira M., Haines G.K., Woods J.M., and Koch A.E. RANTES expression and contribution to monocyte chemotaxis in arthritis. Clin Immunol Immunopathol 89 (1998) 44-53
8. Qiu D., and Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook F. Drugs R D 4 (2003) 1-18
9. Chen B.J. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 42 (2001) 253-265
10. Lipsky P.E., and Tao X.L. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 26 (1997) 713-723
11. Tao X., Davis L.S., Hashimoto K., and Lipsky P.E. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction. J Pharmacol Exp Ther 276 (1996) 316-325
12. Tao X.L., Schulze-Koops H., Ma L., Cai J.J., Mao Y.P., and Lipsky P.E. Effects of Tripterygium wilfordii Hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum 41 (1998) 130-138
13. Tao X., Ma L., Mao Y., and Lipsky P.E. Suppression of carrageenan-induced inflammation in vivo by an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F. Inflamm Res 48 (1999) 139-148
14. Wang B., Ma L., Tao X., and Lipsky P.E. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum 50 (2004) 2995-3003
15. Lin N., Sato T., and Ito A. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook F, suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Arthritis Rheum 44 (2001) 2193-2200
16. Liacini A., Sylvester J., and Zafarullah M. Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes. Biochem Biophys Res Commun 327 (2005) 320-327
17. Kusunoki N., Yamazaki R., Kitasato H., Beppu M., Aoki H., and Kawai S. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol 4 (2004) 2-11
18. Liu M., Dong J., Yang Y., Yang X., and Xu H. Anti-inflammatory effects of triptolide loaded poly (d,l-lactic acid) nanoparticles on adjuvant-induced arthritis in rats. J Ethnopharmacol 97 (2005) 219-225
19. Ogata H., Takeya M., Yoshimura T., Takagi K., and Takahashi K. The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J Pathol 182 (1997) 106-114
20. Katrib A., Tak P.P., Bertouch J.V., Cuello C., McNeil H.P., Smeets T.J., et al. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology (Oxford) 40 (2001) 988-994
21. Colpaert F.C., Meert T., De Witthand P., and Schmitt P. Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci 31 (1982) 67-75
22. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14 (1996) 397-440
23. Kasama T., Strieter R.M., Lukacs N.W., Lincoln P.M., Burdick M.D., and Kunkel S.L. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95 (1995) 2868-2876
24. Barnes D.A., Tse J., Kaufhold M., Owen M., Hesselgesser J., Strieter R., et al. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Clin Invest 101 (1998) 2910-2919
25. Inoue T., Yamashita M., and Higaki M. The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1beta-stimulated synoviocytes of patients with rheumatoid arthritis. Rheumatol Int 20 (2001) 149-153
26. Gong J.H., Ratkay L.G., Waterfield J.D., and Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186 (1997) 131-137
27. Plater-Zyberk C., Hoogewerf A.J., Proudfoot A.E., Power C.A., and Wells T.N. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 57 (1997) 117-120
28. Youssef S., Maor G., Wildbaum G., Grabie N., Gour-Lavie A., and Karin N. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J Clin Invest 106 (2000) 361-371
29. Lu Y., Fukuda K., Nakamura Y., Kimura K., Kumagai N., and Nishida T. Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts. Invest Ophthalmol Vis Sci 46 (2005) 2346-2352
30. Krakauer T., Chen X., Howard O.M., and Young H.A. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol 27 (2005) 53-66
31. Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., et al. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem Biophys Res Commun 345 (2006) 1122-1130
32. Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 274 (1999) 13443-13450
33. Wu Y., Cui J., Bao X., Chan S., Young D.O., Liu D., et al. Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage. Int J Mol Med 17 (2006) 141-150